Treatment of Hodgkin's disease. Results obtained by individualized treatment using radiotherapy and cytostatics.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D012008:Recurrence; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use
D009588:Nitrogen Mustard Compounds; D011344:Procarbazine; D008466:Mechlorethamine; D014747:Vinblastine; D003520:Cyclophosphamide